Total Payments
$7,691
2024 Payments
$1,634
Companies
29
Transactions
128
Medicare Patients
650
Medicare Billing
$120,492
Payment Breakdown by Category
Food & Beverage$7,691 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,691 | 128 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,259 | 17 | $0 (2024) |
| Lilly USA, LLC | $1,155 | 15 | $0 (2024) |
| Novo Nordisk Inc | $1,030 | 21 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $836.90 | 8 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $539.84 | 6 | $0 (2018) |
| ABBVIE INC. | $481.13 | 6 | $0 (2024) |
| PFIZER INC. | $443.04 | 6 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $437.20 | 10 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $261.77 | 9 | $0 (2024) |
| Medtronic USA, Inc. | $186.31 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,634 | 30 | Novo Nordisk Inc ($354.58) |
| 2023 | $699.02 | 21 | Novo Nordisk Inc ($244.48) |
| 2022 | $130.68 | 3 | Lilly USA, LLC ($85.09) |
| 2021 | $154.79 | 3 | Lilly USA, LLC ($115.11) |
| 2020 | $480.96 | 7 | ATRICURE, INC. ($144.90) |
| 2019 | $1,501 | 20 | Boehringer Ingelheim Pharmaceuticals, Inc. ($414.60) |
| 2018 | $1,165 | 19 | Merck Sharp & Dohme Corporation ($281.40) |
| 2017 | $1,926 | 25 | Boehringer Ingelheim Pharmaceuticals, Inc. ($464.77) |
All Payment Transactions
128 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: Hyperthyroidism | ||||||
| 12/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $98.45 | General |
| Category: Diabetes | ||||||
| 11/22/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $28.10 | General |
| Category: Rare Disease | ||||||
| 11/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $118.72 | General |
| Category: Obesity | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $117.76 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Neurology | ||||||
| 09/17/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/12/2024 | Boston Scientific Corporation | Varithena Administration Pack (Device) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Varithena_PI | ||||||
| 07/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.15 | General |
| Category: DIABETES | ||||||
| 06/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $77.47 | General |
| Category: DIABETES | ||||||
| 06/24/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Neurology | ||||||
| 06/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $120.29 | General |
| Category: Obesity | ||||||
| 06/05/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $110.41 | General |
| Category: Obesity | ||||||
| 05/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Obesity | ||||||
| 04/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $118.06 | General |
| Category: IMMUNOLOGY | ||||||
| 04/09/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Neurology | ||||||
| 04/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Obesity | ||||||
| 04/02/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/28/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Diabetes | ||||||
| 03/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $117.76 | General |
| Category: Respiratory | ||||||
| 03/26/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: VACCINES | ||||||
| 03/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $105.47 | General |
| Category: DIABETES | ||||||
| 03/15/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.15 | General |
| 03/05/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $14.90 | General |
| Category: Medical Device | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 203 | 493 | $163,968 | $29,641 |
| 2022 | 3 | 118 | 439 | $81,986 | $29,799 |
| 2021 | 5 | 169 | 394 | $72,226 | $33,885 |
| 2020 | 4 | 160 | 434 | $72,639 | $27,167 |
Total Patients
650
Total Services
1,760
Medicare Billing
$120,492
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 166 | $81,200 | $16,223 | 20.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 118 | $47,200 | $8,215 | 17.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $10,800 | $1,745 | 16.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 11 | 11 | $4,400 | $1,639 | 37.2% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 12 | 31 | $2,604 | $921.01 | 35.4% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 34 | 106 | $6,784 | $446.45 | 6.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 29 | $9,860 | $327.75 | 3.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 14 | $1,120 | $123.48 | 11.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 54 | 208 | $58,921 | $22,553 | 38.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 33 | 84 | $17,625 | $6,558 | 37.2% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 31 | 147 | $5,440 | $687.87 | 12.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 42 | 123 | $30,810 | $15,033 | 48.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 52 | 127 | $26,171 | $12,282 | 46.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 38 | 74 | $12,950 | $6,102 | 47.1% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 26 | 59 | $1,888 | $305.66 | 16.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 11 | 11 | $407.00 | $163.68 | 40.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 61 | 205 | $38,138 | $15,958 | 41.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 68 | 171 | $29,925 | $9,729 | 32.5% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 19 | 40 | $4,000 | $1,412 | 35.3% |
| 96127 | Brief emotional or behavioral assessment | Office | 2020 | 12 | 18 | $576.00 | $68.23 | 11.8% |
About Dr. Thomas Reisman, MD
Dr. Thomas Reisman, MD is a Internal Medicine healthcare provider based in Hicksville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720028756.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Reisman, MD has received a total of $7,691 in payments from pharmaceutical and medical device companies, with $1,634 received in 2024. These payments were reported across 128 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($7,691).
As a Medicare-enrolled provider, Reisman has provided services to 650 Medicare beneficiaries, totaling 1,760 services with total Medicare billing of $120,492. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Hicksville, NY
- Active Since 06/07/2006
- Last Updated 10/08/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1720028756
Products in Payments
- JARDIANCE (Drug) $1,340
- TRULICITY (Drug) $614.27
- Wegovy (Drug) $494.80
- FARXIGA (Drug) $477.90
- ELIQUIS (Drug) $411.51
- XARELTO (Drug) $351.63
- JANUVIA (Drug) $198.47
- ENTRESTO (Drug) $195.48
- INVOKANA (Drug) $188.21
- Victoza (Drug) $166.08
- Leqembi (Drug) $165.19
- Ozempic (Drug) $149.96
- KYPHON Balloon Kyphoplasty (Device) $146.35
- ATRICURE CRYOSURGICAL SYSTEM (Device) $144.90
- ZEPBOUND (Drug) $138.68
- BELSOMRA (Drug) $125.00
- Repatha (Biological) $124.77
- BYDUREON (Drug) $123.48
- Otezla (Drug) $123.47
- SPIRIVA RESPIMAT (Drug) $118.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Hicksville
Sejal Kadam, Md, MD
Internal Medicine — Payments: $14,793
Internal Medicine $14,793
Ranjit Kadam, Md, MD
Internal Medicine — Payments: $10,356
Internal Medicine $10,356
Dr. David Lotfi, M.d, M.D
Internal Medicine — Payments: $7,909
Internal Medicine $7,909
Dr. Reinaldo Gutierrez, M.d, M.D
Internal Medicine — Payments: $6,594
Internal Medicine $6,594
Dr. Mark Nyitray, D.o, D.O
Internal Medicine — Payments: $6,294
Internal Medicine $6,294
Dr. Kauser Yasmeen, Md, MD
Internal Medicine — Payments: $3,976
Internal Medicine $3,976